logo
Plus   Neg
Share
Email

Ciena Board Authorizes $300 Mln Share Buyback - Quick Facts

Ciena (CIEN) announced that its Board has authorized a program to repurchase up to $300 million of the company's common stock through the end of fiscal 2020. The share repurchase program will be funded with cash on hand or cash generated from operations.

Ciena noted that it may purchase shares at management's discretion in the open market, in privately negotiated transactions, in transactions structured through investment banking institutions, or a combination of the foregoing. The company may also, from time to time, enter into Rule 10b5-1 plans to facilitate repurchases of its shares under the authorization.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
eBay Inc. has filed a lawsuit against Amazon.com Inc., accusing its e-commerce rival of illegally poaching sellers on its marketplace by infiltrating eBay's internal messaging system. The lawsuit filed by eBay on Wednesday in Santa Clara County in California, accuses Amazon of having "perpetrated a scheme to infiltrate and exploit eBay's internal member email system" over the past several years. Philip Morris International Inc. (PM) announced, for the third-quarter, reported and adjusted diluted earnings per share was $1.44, up 13.4% versus $1.27 in 2017. Excluding unfavorable currency of $0.09, adjusted diluted earnings per share up by 20.5% to $1.53 from $1.27 in 2017. On average, 13 analysts... Shares of Novartis AG were gaining around 2 percent in the morning trading in Switzerland after the drug major on Thursday lifted its fiscal 2018 net sales guidance, despite weak profit in its third quarter. Core earnings topped analysts' estimates, while net sales missed their view, despite a growth. Further, Novartis announced an agreement to buy Endocyte, a US-based biopharmaceutical company.
Follow RTT